一项全基因组关联研究与机器学习方法相结合,以确定影响帕金森病背后的人口和基因组因素
Md Asad Rahman1, Jinling Liu1,2
1Department of Engineering Management and Systems Engineering, Missouri University of Science and Technology, Rolla, MO, United States.
Frontiers in genetics
|October 16, 2023
概括
这项研究结合了全基因组关联研究 (GWAS) 和机器学习 (ML) 来确定帕金森病 (PD) 风险预测的人口统计和遗传因素. 开发的模型实现了强大的预测性能,突出了PD病因学的新见解.
科学领域:
- 遗传学 遗传学 是一个
- 神经学 神经学
- 计算生物学 计算生物学
背景情况:
- 尽管最近在全基因组关联研究 (GWAS) 中取得了进展,但帕金森病 (PD) 风险预测仍然具有挑战性.
- 确定可靠的人口和基因组因素对于临床风险评估至关重要.
- 目前对PD的基因组基础的理解需要进一步阐明.
研究的目的:
- 确定与PD相关的具有影响力的人口和基因组因素.
- 开发和比较用于PD风险预测的机器学习 (ML) 模型.
- 揭示PD涉及的新型遗传变异和途径.
主要方法:
- 利用了来自福克斯洞察研究的人口统计 (200个变量,33,473名参与者) 和基因组 (447,089个SNP,8,840个样本) 数据.
- 应用相关性,GWAS和ML分析用于因子识别和PD预测.
- 进行特征重要性分析和基因组丰富分析.
主要成果:
- 确定了与PD相关的新的和已知的人口和遗传因素.
- 开发了具有AUC = 0.89 (人口统计学) 和AUC = 0.74 (基因组学) 的预测模型.
- 在LMNA,SEMA4A,RIT1,DCST1和KCNN3中发现了显著的变异,其中一些可能会被传统的GWAS遗漏.
结论:
- 将GWAS与ML结合起来,可以有效地识别PD的人口和基因组预测因素.
- 这项研究为PD风险预测和发现新型遗传关联提供了一个强大的框架.
- 这些发现有助于更深入地了解PD复杂的遗传结构和潜在的治疗点.
更多相关视频
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.2K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.0K
相关概念视频
01:11Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K
01:15Parkinson's Disease: Overview
579
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
579